Connection
Robert MacLaren to Propofol
This is a "connection" page, showing publications Robert MacLaren has written about Propofol.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.911 |
|
|
|
-
Moore GD, Walker AM, MacLaren R. Fospropofol: a new sedative-hypnotic agent for monitored anesthesia care. Ann Pharmacother. 2009 Nov; 43(11):1802-8.
Score: 0.314
-
MacLaren R, Sullivan PW. Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patients. Pharmacotherapy. 2005 Oct; 25(10):1319-28.
Score: 0.237
-
Buckley MS, Agarwal SK, MacLaren R, Kane-Gill SL. Adverse Hemodynamic Events Associated With Concomitant Dexmedetomidine and Propofol for Sedation in Mechanically Ventilated ICU Patients. J Intensive Care Med. 2020 Dec; 35(12):1536-1545.
Score: 0.158
-
MacLaren R, Wachsman BA, Swift DK, Kuhl DA. Warfarin resistance associated with intravenous lipid administration: discussion of propofol and review of the literature. Pharmacotherapy. 1997 Nov-Dec; 17(6):1331-7.
Score: 0.137
-
MacLaren R, Forrest LK, Kiser TH. Adjunctive dexmedetomidine therapy in the intensive care unit: a retrospective assessment of impact on sedative and analgesic requirements, levels of sedation and analgesia, and ventilatory and hemodynamic parameters. Pharmacotherapy. 2007 Mar; 27(3):351-9.
Score: 0.065